Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy.

Ransom CE, Huo Y, Patel K, Scott GB, Watts HD, Williams P, Siberry GK, Livingston EG; P1025 Team of the International Maternal Pediatric Adolescent AIDS Clinical Trials Group.

J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):374-81. doi: 10.1097/QAI.0b013e3182a7adb2.

2.

Tenofovir-related Fanconi's syndrome and osteomalacia in a teenager with HIV.

Lucey JM, Hsu P, Ziegler JB.

BMJ Case Rep. 2013 Jul 9;2013. pii: bcr2013008674. doi: 10.1136/bcr-2013-008674.

3.

Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors.

Pontrelli G, Cotugno N, Amodio D, Zangari P, Tchidjou HK, Baldassari S, Palma P, Bernardi S.

BMC Infect Dis. 2012 Jan 23;12:18. doi: 10.1186/1471-2334-12-18.

4.

Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.

Nagle MA, Truong DM, Dnyanmote AV, Ahn SY, Eraly SA, Wu W, Nigam SK.

J Biol Chem. 2011 Jan 7;286(1):243-51. doi: 10.1074/jbc.M110.139949. Epub 2010 Oct 4.

5.

Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors.

Andiman WA, Chernoff MC, Mitchell C, Purswani M, Oleske J, Williams PL, Spiegel H, Gona P, Seage GR 3rd; PACTG iDACS 617 Study Team.

Pediatr Infect Dis J. 2009 Jul;28(7):619-25. doi: 10.1097/INF.0b013e31819ca49a.

6.

Kidney disease in HIV-positive children.

McCulloch MI, Ray PE.

Semin Nephrol. 2008 Nov;28(6):585-94. doi: 10.1016/j.semnephrol.2008.09.001. Review.

Items per page

Supplemental Content

Write to the Help Desk